Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

Summary

The aim of the clinical study is to study the safety, reactogenicity and immunogenicity indicators of the EpiVacCorona vaccine, with the involvement of volunteers aged 60 years and above. The research tasks are to: * to evaluate the safety of the EpiVacCorona vaccine when administered twice intramuscularly, with the participation of volunteers aged 60 years and older; * to evaluate the reactogenicity of the EpiVacCorona vaccine when administered twice intramuscularly, with the participation of volunteers aged 60 years and older; * to identify any adverse effects to the administration of the vaccine; * to study the humoral and cellular immune responses response following two doses of the EpiVacCorona vaccine, with the participation of volunteers aged 60 and older.

Timeline

Start

2020-11-19

Primary completion

2021-01-30

Completion

2021-01-30

Drugs

Indications